A Comparison of Clinical Manifestations and Outcomes between Acute Sporadic Hepatitis A and Hepatitis E Infections in Thailand.
Thailand
clinical presentation
hepatitis A
hepatitis E
outcome
Journal
Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722
Informations de publication
Date de publication:
07 09 2023
07 09 2023
Historique:
received:
01
08
2023
revised:
28
08
2023
accepted:
05
09
2023
medline:
29
9
2023
pubmed:
28
9
2023
entrez:
28
9
2023
Statut:
epublish
Résumé
Hepatitis A virus (HAV) and hepatitis E virus (HEV) infections often present as acute hepatitis with prodromal symptoms. These infections, transmitted via the oral-enteral route, constitute significant public health challenges, particularly in developing countries with subpar sanitary systems. The aim of the study was to describe the clinical manifestations, laboratory findings, and outcomes of hepatitis A and hepatitis E infections in Thailand. We conducted a retrospective chart review and analysis of 152 patients diagnosed with acute hepatitis A or hepatitis E from January 2007 to August 2018 at Siriraj Hospital. The hepatitis E cohort was older with a greater prevalence of comorbidities (hypertension, diabetes mellitus, chronic kidney disease, chronic hepatitis B, and post-kidney transplantation status) than the hepatitis A cohort. While the majority of hepatitis A patients presented with fever (98%) and jaundice (96%), these symptoms were less pronounced in hepatitis E patients. Furthermore, hepatitis A patients exhibited significantly higher aminotransferase and total bilirubin levels. However, clinical outcomes, such as hospitalization rates, progression to acute liver failure, and mortality, were comparable across both groups. In conclusion, although the clinical manifestations of hepatitis A and hepatitis E were similar, fever and jaundice were more prevalent and aminotransferase and bilirubin levels were higher in the HAV-infected group.
Identifiants
pubmed: 37766294
pii: v15091888
doi: 10.3390/v15091888
pmc: PMC10538055
pii:
doi:
Substances chimiques
Bilirubin
RFM9X3LJ49
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Southeast Asian J Trop Med Public Health. 1996 Dec;27(4):650-3
pubmed: 9253861
J Med Microbiol. 2014 Jul;63(Pt 7):975-980
pubmed: 24821066
N Engl J Med. 2012 Sep 27;367(13):1237-44
pubmed: 23013075
Intervirology. 2010;53(1):15-9
pubmed: 20068336
Transfus Med. 2017 Apr;27(2):84-95
pubmed: 28382704
Gastroenterol Clin North Am. 2020 Jun;49(2):191-199
pubmed: 32389358
BMC Res Notes. 2018 Sep 3;11(1):640
pubmed: 30176927
Adv Exp Med Biol. 2016;948:175-189
pubmed: 27738985
J Clin Virol. 2022 Aug;153:105219
pubmed: 35753174
J Med Microbiol. 2018 Apr;67(4):466-480
pubmed: 29485390
World J Gastroenterol. 2016 Aug 21;22(31):7030-45
pubmed: 27610014
Eur J Gastroenterol Hepatol. 2008 Aug;20(8):784-90
pubmed: 18617784
Intervirology. 1999;42(4):252-62
pubmed: 10567844
Hepatol Res. 2005 May;32(1):16-24
pubmed: 15914081
Nat Rev Dis Primers. 2017 Nov 16;3:17086
pubmed: 29154369
Am J Epidemiol. 1985 Aug;122(2):226-33
pubmed: 3860002
J Gastroenterol Hepatol. 2007 May;22(5):676-82
pubmed: 17444855
Infect Genet Evol. 2013 Mar;14:335-9
pubmed: 23333774
Viral Immunol. 2019 Sep;32(7):302-307
pubmed: 31403386
Virol J. 2021 Jul 12;18(1):145
pubmed: 34247642
Clin Microbiol Rev. 2001 Jan;14(1):38-58
pubmed: 11148002
Mol Biol Rep. 2020 Nov;47(11):8657-8668
pubmed: 33058031
Indian J Med Microbiol. 2015 Feb;33 Suppl:102-5
pubmed: 25657123
Ann Intern Med. 2007 Jul 3;147(1):28-33
pubmed: 17606958
Pathogens. 2020 Oct 11;9(10):
pubmed: 33050666
J Med Virol. 2013 Aug;85(8):1369-76
pubmed: 23703666
PLoS One. 2021 Dec 1;16(12):e0258659
pubmed: 34851983
Virus Res. 2011 Oct;161(1):15-22
pubmed: 21458513
J Infect Dis. 1995 Mar;171 Suppl 1:S15-8
pubmed: 7876641
Clin Microbiol Rev. 2006 Jan;19(1):63-79
pubmed: 16418523
Int J Infect Dis. 2019 Sep;86:114-121
pubmed: 31279609
MMWR Recomm Rep. 2006 May 19;55(RR-7):1-23
pubmed: 16708058
Euro Surveill. 2019 Mar;24(10):
pubmed: 30862337
Am J Med. 1981 Feb;70(2):252-5
pubmed: 6781338
Emerg Microbes Infect. 2018 Feb 7;7(1):11
pubmed: 29410449
J Med Virol. 2015 Jul;87(7):1218-24
pubmed: 25881081
World J Gastroenterol. 2020 Oct 7;26(37):5543-5560
pubmed: 33071523
Acta Virol. 2020;64(1):20-27
pubmed: 32180415
Ann Hepatol. 2012 Sep-Oct;11(5):652-7
pubmed: 22947525
J Hepatol. 2020 Mar;72(3):578-580
pubmed: 31173809
Arch Virol. 2010 Oct;155(10):1697-9
pubmed: 20628771
J Med Virol. 2014 Oct;86(10):1730-5
pubmed: 24984976
J Viral Hepat. 2014;21(9):605-15
pubmed: 25040644
Cold Spring Harb Perspect Med. 2018 Sep 4;8(9):
pubmed: 29440324